Baseline Characteristics Module
The Baseline Characteristics Module provides demographic and baseline characteristics information for participants in a clinical trial. This module includes data such as population descriptions and the types of units analyzed, helping researchers understand the baseline characteristics of study participants.
Baseline Characteristics Module path is as follows:
Study -> Results Section -> Baseline Characteristics Module
Baseline Characteristics Module
Ignite Creation Date:
2025-12-24 @ 3:29 PM
Ignite Modification Date:
2025-12-25 @ 1:44 PM
NCT ID:
NCT01999192
Population Description:
8 subjects of 321 who had no post-baseline assessment were excluded from the Full Analysis Set (FAS), (one subject \[1.3%\] in the placebo group, three subjects \[3.6%\] in Dose Level 1 Tregalizumab group, two subjects \[2.5%\] in Dose Level 2 Tregalizumab group, and two subjects \[2.6%\] in Dose Level 3 Tregalizumab group).
Study:
NCT01999192
Study Brief:
Results Section:
NCT01999192